2.25
+0.73(+48.03%)
Currency In USD
| Previous Close | 1.52 |
| Open | 2.16 |
| Day High | 2.45 |
| Day Low | 1.88 |
| 52-Week High | 214.8 |
| 52-Week Low | 1.46 |
| Volume | 36.45M |
| Average Volume | 1.84M |
| Market Cap | 3.36M |
| PE | 0.01 |
| EPS | 277.2 |
| Moving Average 50 Days | 2.26 |
| Moving Average 200 Days | 4.39 |
| Change | 0.73 |
If you invested $1000 in Bluejay Diagnostics, Inc. (BJDX) since IPO date, it would be worth $0.05 as of June 07, 2025 at a share price of $2.25. Whereas If you bought $1000 worth of Bluejay Diagnostics, Inc. (BJDX) shares 3 years ago, it would be worth $0.26 as of June 07, 2025 at a share price of $2.25.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Bluejay Diagnostics Provides Mid-Year Business and Corporate Update
GlobeNewswire Inc.
Jun 03, 2025 8:05 PM GMT
ACTON, Mass., June 03, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical diagnostics company developing rapid near-patient testing solutions for critical care, today provided a 2025 mid-year b
Bluejay Announces Abstract Accepted for Presentation at the 2025 Society of Academic Emergency Medicine (SAEM) Annual Meeting
GlobeNewswire Inc.
Apr 15, 2025 11:00 AM GMT
New clinical data from the SYMON-I study to evaluate IL-6 in sepsis patients to be presented.ACTON, Mass., April 15, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX), today announced acceptance of an abstract related to the Symphon
Bluejay Diagnostics Announces Entry into Warrant Inducement Transaction for Approximately $3.7 Million in Gross Proceeds
GlobeNewswire Inc.
Apr 07, 2025 9:21 PM GMT
ACTON, Mass., April 07, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical technology company developing rapid diagnostics on its Symphony platform to improve patient outcomes in critical care